中文 | English
Return
Total: 308 , 1/31
Show Home Prev Next End page: GO
Author:(Hong Bo MA)

1.Construction of a postoperative mortality risk model for patients with acute aortic dissection based on XGBoost-SHAP method

Xin ZHANG ; Min FANG ; Yi CAO ; Ting-Ting LI ; Xian-Kong LIU ; Jia-Yi DANG ; Xue-Sen ZHAO ; Hong-Qin REN ; Jia-Ze GENG ; Kai-Wen WANG ; Tie-Sheng HAN ; Yong-Bo ZHAO ; Dong MA

Medical Journal of Chinese People's Liberation Army 2025;50(10):1226-1234

2.Analysis of factors influencing global longitudinal strain based on cardiac magnetic resonance after acute myocardial infarction

Ke LIU ; Yi-Qing ZHAO ; Zhen-Yan MA ; Xin A ; Li LI ; Wei-Ran KONG ; Lei ZHAO ; Hong-Bo ZHANG ; Ying ZHANG ; Geng QIAN

Medical Journal of Chinese People's Liberation Army 2025;50(11):1382-1389

3.Association of digit ratio with polymorphisms at three loci of matrix metalloproteinase 9 gene in Ningxia Han youths

Meng-Yi YANG ; Jin ZHANG ; Shi-Bo NIU ; Jie DANG ; Zhan-Bing MA ; Hong LU ; Zheng-Hao HUO ; Yu XU ; Dan SHEN

Acta Anatomica Sinica 2025;56(1):74-79

4.Atomic Fluorescence Dispersion Detection Technique Based on Area Array Single Photon Counting Imaging Detector

Chen TAO ; Hong-Ji ZHANG ; Chun-Sheng LI ; Ling-Ping HE ; Zhen-Yu MA ; Bo CHEN ; Ran ZHANG

Chinese Journal of Analytical Chemistry 2025;53(2):187-194

5.Changes and Trends in the microbiological-related standards in the Chinese Pharmacopoeia 2025 Edition

FAN Yiling ; ZHU Ran ; YANG Yan ; JIANG Bo ; SONG Minghui ; WANG Jing ; LI Qiongqiong ; LI Gaomin ; WANG Shujuan ; SHAO Hong ; MA Shihong ; CAO Xiaoyun ; HU Changqin ; MA Shuangcheng, ; YANG Meicheng

Drug Standards of China 2025;26(1):093-098

6.Progress in the study of anti-inflammatory active components with anti-inflammatory effects and mechanisms in Caragana Fabr.

Yu-mei MA ; Ju-yuan LUO ; Tao CHEN ; Hong-mei LI ; Cheng SHEN ; Shuo WANG ; Zhi-bo SONG ; Yu-lin LI

Acta Pharmaceutica Sinica 2025;60(1):58-71

7.GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers

Yi-Tong LI ; Wei-Qing SHAO ; Zhen-Mei CHEN ; Xiao-Chen MA ; Chen-He YI ; Bao-Rui TAO ; Bo ZHANG ; Yue MA ; Guo ZHANG ; Rui ZHANG ; Yan GENG ; Jing LIN ; Jin-Hong CHEN

Clinical and Molecular Hepatology 2025;31(2):409-425

8.GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers

Yi-Tong LI ; Wei-Qing SHAO ; Zhen-Mei CHEN ; Xiao-Chen MA ; Chen-He YI ; Bao-Rui TAO ; Bo ZHANG ; Yue MA ; Guo ZHANG ; Rui ZHANG ; Yan GENG ; Jing LIN ; Jin-Hong CHEN

Clinical and Molecular Hepatology 2025;31(2):409-425

9.Changes and Trends in the microbiological-related standards in the Chinese Pharmacopoeia 2025 Edition

Yiling FAN ; Ran ZHU ; Yan YANG ; Bo JIANG ; Minghui SONG ; Jing WANG ; Qiongqiong LI ; Gaomin LI ; Shujuan WANG ; Hong SHAO ; Shihong MA ; Xiaoyun CAO ; Changqin HU ; Shuangcheng MA ; Meicheng YANG ; Jun ZHANG

Drug Standards of China 2025;26(1):93-98

10.GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in metabolic dysfunction-associated steatohepatitis livers

Yi-Tong LI ; Wei-Qing SHAO ; Zhen-Mei CHEN ; Xiao-Chen MA ; Chen-He YI ; Bao-Rui TAO ; Bo ZHANG ; Yue MA ; Guo ZHANG ; Rui ZHANG ; Yan GENG ; Jing LIN ; Jin-Hong CHEN

Clinical and Molecular Hepatology 2025;31(2):409-425

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 308 , 1/31 Show Home Prev Next End page: GO